← Back to Search

Treatment for Delirium

N/A
Recruiting
Led By Timothy Girard, MD
Research Sponsored by Ceribell Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-8 hours per day, for a maximum of six (6) days
Awards & highlights

Summary

This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-8 hours per day, for a maximum of six (6) days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-8 hours per day, for a maximum of six (6) days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Perform Confusion Assessment Method for the ICU (CAM-ICU) assessment
Perform Electroencephalogram (EEG) Test

Find a Location

Who is running the clinical trial?

Ceribell Inc.Lead Sponsor
1 Previous Clinical Trials
164 Total Patients Enrolled
Timothy Girard, MDPrincipal InvestigatorUniversity of Pittsburgh
Jose Maldonado, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
30 Total Patients Enrolled
~16 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top